Dose escalation study on oxaliplatin and Capecitabine (Xeloda) in patients with advanced solid tumorsKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2004, Vol 66, Num 4, pp 253-259, issn 0030-2414, 7 p.Article

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumoursANDROULAKIS, N; KOUROUSSIS, C; GEORGOULIAS, V et al.European journal of cancer (1990). 2002, Vol 38, Num 15, pp 1992-1997, issn 0959-8049Article

A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancerAGELAKI, S; KAKOLYRIS, S; PALAMIDAS, Ph et al.Lung cancer. 2001, Vol 34, Num 1, pp 133-139, issn 0169-5002Article

Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (cl) of 5-fluorouracil (5-Fu) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanesKALBAKIS, K; KOUROUSSIS, Ch; KAKOLYRIS, S et al.British journal of cancer. 2001, Vol 85, Num 6, pp 798-802, issn 0007-0920Article

Phase I study of the gemcitbine/oxaliplatin combination in patients with advanced solid tumors : A preliminary reportMAVROUDIS, D; KOUROUSIS, C; KAKOLYRIS, S et al.Seminars in oncology. 2000, Vol 27, Num 1, pp 25-30, issn 0093-7754, SUP2Article

Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research GroupKENTEPOZIDIS, N; KOTSAKIS, A; SAMONIS, G et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 3, pp 605-612, issn 0344-5704, 8 p.Article

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy : evaluation of their clinical relevanceAPOSTOLAKI, S; PERRAKI, M; VAMVAKAS, L et al.Annals of oncology. 2007, Vol 18, Num 5, pp 851-858, issn 0923-7534, 8 p.Article

Salvage treatment of metastatic breast cancer with docetaxel and carboplatin: A multicenter phase II trialMAVROUDIS, D; ALEXOPOULOS, A; GEORGOULIAS, V et al.Oncology. 2003, Vol 64, Num 3, pp 207-212, issn 0030-2414, 6 p.Article

Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancerKAKOLYRIS, S; KOUROUSSIS, Ch; SOUGLAKOS, J et al.Lung cancer. 2001, Vol 34, pp S71-S76, issn 0169-5002, SUP4Conference Paper

Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) : A phase II trialMAVROUDIS, D; KOUROUSIS, C; SARMONIS, G et al.American journal of clinical oncology. 2000, Vol 23, Num 4, pp 341-344, issn 0277-3732Article

Front-line treatment of metastatic breast cancer with docetaxel and epirubicin : A multicenter dose-escalation studyKOUROUSSIS, C; XYDAKIS, E; SAMONIS, G et al.Annals of oncology. 1999, Vol 10, Num 5, pp 547-552, issn 0923-7534Article

Treatment of non-small-cell lung cancer with prolonged oral etoposideKAKOLYRIS, S; SAMONIS, G; KOUKOURAKIS, M et al.American journal of clinical oncology. 1998, Vol 21, Num 5, pp 505-508, issn 0277-3732Article

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancerANDROULAKIS, N; AGELAKI, S; PERRAKI, M et al.British journal of cancer. 2012, Vol 106, Num 12, pp 1917-1925, issn 0007-0920, 9 p.Article

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancerDASKALAKI, A; AGELAKI, S; PERRAKI, M et al.British journal of cancer. 2009, Vol 101, Num 4, pp 589-597, issn 0007-0920, 9 p.Article

A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursBOZIONELOU, V; VAMVAKAS, L; GEORGOULIAS, V et al.British journal of cancer. 2007, Vol 97, Num 1, pp 43-49, issn 0007-0920, 7 p.Article

Phase I study of Paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) administered every 2 weeks in patients with advanced solid tumorsMAVROUDIS, D; KOUROUSSIS, Ch; KAKOLYRIS, S et al.Oncology. 2002, Vol 62, Num 3, pp 216-222, issn 0030-2414Article

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II studyKAKOLYRIS, S; PAPADAKIS, E; AGELAKI, S et al.Lung cancer. 2001, Vol 32, Num 2, pp 179-187, issn 0169-5002Article

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapyKAKOLYRIS, S; SOUGLAKOS, J; AGELAKI, S et al.Lung cancer. 2000, Vol 30, Num 3, pp 193-198, issn 0169-5002Article

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma : a multicentre phase I studyGIANNAKAKIS, T; ZIRAS, N; VLACHONIKOLIS, J et al.European journal of cancer (1990). 2000, Vol 36, Num 6, pp 742-747, issn 0959-8049Article

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancerXENIDIS, N; PERRAKI, M; GEORGOULIAS, V et al.British journal of cancer. 2013, Vol 108, Num 3, pp 549-556, issn 0007-0920, 8 p.Article

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapyPALLIS, A. G; AGELAKI, S; HATZIDAKI, D et al.Lung cancer. 2008, Vol 62, Num 3, pp 356-363, issn 0169-5002, 8 p.Article

A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumorsKARAMPEAZIS, A; VAMVAKAS, L; AGELAKI, S et al.Oncology. 2006, Vol 71, Num 5-6, pp 347-353, issn 0030-2414, 7 p.Article

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer : A phase II trialSOUGLAKOS, J; PALLIS, A; KAKOLYRIS, S et al.Oncology. 2005, Vol 69, Num 5, pp 384-390, issn 0030-2414, 7 p.Article

Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase ii studyALEXOPOULOS, A; KOUROUSSIS, C; RIGATOS, G et al.Annals of oncology. 2001, Vol 12, Num 6, pp 793-798, issn 0923-7534Article

Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor : A phase II study of the Greek Cooperative Group for Pancreatic CancerSTATHOPOULOS, G. P; MAVROUDIS, D; TSAVARIS, N et al.Annals of oncology. 2001, Vol 12, Num 1, pp 101-103, issn 0923-7534Article